We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
X-Men star Hugh Jackman has called on people to use sunscreen after having a cancerous growth removed from his face.
An Indian soldier has been found alive six days after an avalanche hit the Siachen glacier in the Himalayas.
A cruise ship had to abandon its voyage to the Bahamas after being caught up in hurricane-like conditions off the US coast at the weekend.